Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8916299 | 0.92 | MAPT (0.54) | CA1CA2CA7CA9MAPT | |
| SCHEMBL10716838 | 0.90 | MAOA (0.52) | CA1CA2CA7CA9MAPT | |
| SCHEMBL2072999 | 0.88 | MAPT (0.52) | CA1CA2CA7CA9MAPT | |
| SCHEMBL13487411 | 0.88 | PTPRC (0.59) | CA1CA2CA7CA9MAPT | |
| SCHEMBL13487412 | 0.84 | CA1 (0.52) | CA1CA2CA7CA9MAPT | |
| SCHEMBL760904 | 0.83 | ADORA2A (0.57) | CA1CA2CA7CA9MAPT | |
| SCHEMBL31307459 | 0.83 | CA1 (0.43) | CA1CA2CA7CA9MAPT | |
| SCHEMBL22730644 | 0.81 | PTPRC (0.49) | CA1CA2CA7CA9MAPT | |
| SCHEMBL7805629 | 0.80 | CA1 (0.44) | CA1CA2CA7CA9MAPT | |
| SCHEMBL9810988 | 0.80 | PTPN1 (0.47) | CA1CA2CA7CA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1349822-B1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2016-09-28 | — | — | EP | disclosed |
| EP-1349822-B1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2016-09-28 | — | — | EP | disclosed |
| US-7018685-B2 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2006-03-28 | — | — | US | disclosed |
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2004-07-01 | — | — | US | disclosed |
| EP-1349822-A1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | CLARIANT INTERNATIONAL LTD. (CH) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002055463-A1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | CLARIANT INTERNATIONAL LTD. (CH) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | AFF1, AFF2, FLI1 | CA1 671/4885CA2 414/4885CA7 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.